Online Self-help for Depressed Patients Awaiting Psychotherapy

Major Depressive Disorder Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01226238
• Other study ID #: Deprexis-HH-HL-WL
• Status: Terminated
• Phase: N/A
• First received: October 20, 2010
• Last updated: June 25, 2014
• Start date: October 2010

Study information

• Verified date: June 2014
• Source: University of Luebeck
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

Patients with major depression who are on a waiting list for psychotherapy usually suffer from considerable symptoms. Online self-help is one potential way to alleviate this suffering. The investigators want to study if patients awaiting psychotherapy benefit from online-self help. The investigators therefore randomly assign patients to either online self-help or no intervention and assess their depressive symptoms on a regular basis. The investigators hypothesize that online self-help will be superior to no intervention in alleviating depressive symptoms in depressed patients awaiting psychotherapy.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 230
• Est. primary completion date: June 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Major Depressive Disorder

• stable medication

• 18yrs. or older

Exclusion Criteria:

• current psychotherapy

• acute suicidality

• unavailability of internet connection

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Depressive Disorder, Major
• Major Depressive Disorder

Intervention

Other:
• Online self-help
Provision of online self-help

Locations

Country	Name	City	State
Germany	MVZ Falkenried	Hamburg

Sponsors (1)

Lead Sponsor	Collaborator
University of Luebeck

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depressive Symptomatology		up to 16 weeks	No
Secondary	Depressive Symptomatology		6 weeks, up to 10 months	No